Background:
INTRODUCTION
Bisphenol A (BPA) is an organic compound used in the industrial production of polycarbonates and epoxy resins [1] . However, BPA is an endocrine disruptor, with potential toxicity in vitro [2] and in vivo [3] . Among other effects, it can cause changes in the structure of the unborn child's mammary glands -promoting further tumor development -and has effects on the brain and behavior, the female reproductive system, and metabolism and obesity [4] . Infants, young children and pregnant or lactating women are the most sensitive [5] . Thus, the manufacturing of baby bottles containing BPA has been banned by the European Union since 2011. From January 1, 2015, France has banned BPA in all food packaging. In its latest comprehensive re-evaluation of BPA exposure and toxicity, the European Food Safety Authorities has concluded no risks at actual exposure levels [6] . However, a lower Tolerable Daily Intake (TDI) has been set at 4µg/kg bw/day (ie 12.5 times less than the last TDI). Besides, its possible "low-dose effect" [7 -9] , defined as "any biological changes occurring in the range of typical human exposures, or biological changes that occur at doses below those used in traditional toxicology studies" was suspected.
Pure BPA is not a component of dental composite resins. However, derivatives of BPA -from pure BPA -are widely used: bisphenol A diglycidyl methacrylate (bis-GMA) especially, but also bisphenol A dimethacrylate (bis-DMA), polycarbonate-modified bis-GMA (PC bis-GMA), ethoxylated bisphenol A glycol dimethacrylate (bis-EMA) and 2,2-bis[(4-methacryloxy polyethoxy)phenyl]propane (bis-MPEPP).
Several studies have investigated the levels of BPA and its derivatives in the saliva or urine after polymerization of a restoration made of a composite resin containing at least one of these monomers. The results vary: some studies in vitro [10] and in vivo [11] have detected some levels (in very low doses) and others do not detect any [12] . This BPA elution would result from impurities in the synthesis of resins or their degradation [13] . These variations can be explained by the different susceptibility of BPA derivatives to hydrolysis by salivary esterases. Bis-GMA does not undergo this reaction, because its chemical structure with stable ether bonds prevents hydrolysis. However, bis-DMA hydrolyzes at its ester bonds, releasing an amount of BPA that is not negligible. These differences could also be related to the detection technique [14] . Furthermore, a recent study showed absorption of BPA by the sublingual area in dogs, allowing its direct entry into the bloodstream, by passing the digestive system and liver and multiplying its bioavailability by a factor of 80 [15] .
Yet, the exact composition of the composite resins on the market and the potential composite resins without BPA derivatives are not known. No study has sought to identify all monomers contained in the marketed composite resins.
The objectives of this study were first, to provide an exhaustive list of the composite resins sold in Europe and detail their composition and second, to estimate the number of composite resins using BPA or BPA derivatives (bis-GMA, bis-DMA, bis-EMA, bis-MPEPP, PC bis-GMA) in their manufacturing.
MATERIALS AND METHODOLOGY
To reference all composite resins sold in Europe, a search was conducted of the manufacturers' websites. Next, the composition of the composite resins was searched on the materials' safety data sheet (MSDS) and using a standardized questionnaire sent to manufacturers. This questionnaire listed 13 monomers found in the MSDS and in the various studies of these materials; the manufacturer had to indicate, for each product, if the material contained these monomers or not, or else write "not disclosed" (ND). The manufacturer could also add monomers to the proposed list ( Table 1) . Manufacturers were contacted by email and/or telephone and the details were transmitted by email; they had 4 months to answer and an extra 2 months after a reminder email. When the manufacturer had not answered or the information was not available (MSDS, internet), the result was noted as "ND". All results were recorded and analyzed by using Microsoft Excel 2008, v12.3.6. 
RESULTS
A total of 160 composite resins were identified from 31 companies ( Table 2) ; 23 companies (74.2%) responded to the survey, with complete responses for 119/135 composite resins they marketed (88%). For the 8 manufacturers who did not respond (25.8%), the search of the internet and especially the MSDS provided responses for 11 of the 25 composite resins marketed (44%). In total, 12 monomers were found in these 130 (119+11) composite resins; pure BPA was never reported. Table 3 reports their frequency of use. 
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DISCUSSION
The adverse estrogenic effects of BPA are well established, which explains the new regulations banning this molecule, especially in food containers [4] . The elution of BPA sometimes detected after the making of a composite resin restoration remains far below toxic levels and at a certain time after placement, unpolymerized monomers would be completely absorbed into saliva, posing little risk of chronic low-dose BPA exposure, so some authors still encourage the use of molecules made from BPA [14, 16] .
However, two factors seem to follow the recommendations against BPA content in composite resins. The first is related to the 2008 results of Bellinger et al. [17] , who demonstrated that in children 6 to 10 years' old, the presence of composite resins was associated with a psychosocial behavior that was worse than with amalgams. These results were confirmed and clarified by Maserejian et al. in 2012 [18] , who indicated that the psychosocial behavior was worse for children with bis-GMA than UDMA composite resin restorations. Fortunately, the last studies of this team are more reassuring concerning sealants and fluid composite resin [19] and concerning the renal function of the children [20] or their immunity markers [21] . Recently, Maserejian et al. [22] in 2016 showed that placement of bis-GMA-based restorations in children and adolescents may temporarily increase BPA concentration in urine, but no longer detectable 14 days or 6 months after treatment. Second, BPA may have greater effects at low than high doses. Wozniack et al. [23] registered effects at doses of 1 pmol. The American National Toxicology Program [24] states that these low-dose effects can occur from 0.23 mg/L. This theory remains controversial [25] . However, the European Food Safety Authority decided last year recently to divide by 10 the maximum daily dose allowed (or 5 mg/kg/day).
Moreover, exposure to BPA during gestation could induce increased spontaneous abortion, abnormal gestation time, reduced birth weight, increased male genital abnormalities, childhood obesity, but also altered behavior, disrupted neurodevelopment in children and increased asthma risk [26] . Because of these potential adverse developmental effects after prenatal exposure to BPA, it would be cautious to limit exposure to unpolymerized dental resin materials during pregnancy. Thus, it could be relevant to select composite resins that do not contain these derivatives for at-risk populations, such pregnant women [27] and as children [28] .
Moreover, patients may ask about the possible bis-GMA content of composite resins. Whatever the opinion of the practitioner, he or she must know the composition of the composite resins used. In this study, 160 composite resins currently marketed by 31 manufacturers in Europe were identified. The composition of 130 (marketed by 23 manufacturers) was established: 112 (86.2%) contain BPA derivatives. Although we had a good response rate (74.2%), we could not obtain the composition of all the products because of strategic reasons, lack of reliable representatives or trade secrets.
In total, 25.8% of the manufacturers did not agree to communicate the composition of their composite resins. They are not required to indicate the exact composition of the materials, which should be required as for drugs. MSDS forms indicate the product's composition only partially, often mentioning only the family of the molecules.
However, we should be cautioned against choosing one of the 18 composite resins without BPA derivatives: the latter contain other monomers that are not necessarily more biocompatible. Indeed, BPA is not the only potentially toxic monomer in composite resins; others may be toxic [29] . In particular, the structure of TEGDMA and HEMA can be degraded by salivary esterases and result in liposoluble metabolites that could accumulate in fatty tissues [30] . Even UDMA, deemed less risky, may present some cytotoxicity beyond a certain concentration [31] . Whatever the composite resin, a certain rate of unpolymerized monomers is released, which is associated with their characteristics, the degree of polymerization and the release medium [32] .
Indirect and CAD-CAM composite restorations maximize the conversion rate and thus minimize the release. Certain procedures reduce exposure to free monomers due to direct composite restorations: rubber dam use, prolonged curing (up to double the recommended time) or a second curing step after covering the restoration with glycerin. In addition, these free monomers are mostly present on the surface of the material, where the exposure to oxygen inhibits polymerization. Hence, Rueggeberg et al. [33] and Komurcuoglu et al. [34] showed that brushing the restoration's surface with pumice allowed for removal of the inhibition layer and eliminated more than 90% of the residual monomers. Applying a dry or wet cotton roll and, to a lesser extent, water/air spray also enables their withdrawal up to 70%. Sasaki et al. [35] showed that gargling with warm water for 30 sec after placement of the composite resin may reduce salivary levels of BPA.
Finally, using alternative materials without resin would be ideal; some high-viscosity glass ionomers or inorganic biomaterials, carbomers (albeit with lower mechanical and aesthetic properties) or ceramic (for extended restorations) may be considered.
CONCLUSION
This study has established a list of 18 BPA derivative-free products that can be used on a daily basis by the general practitioner. The respective long-term effects on human health of the different monomers remain unclear and deserve to be the subject of cohort studies.
Manufacturers should be required to report the exact composition of their products, as is required in the pharmaceutical industry, so that practitioners are able to communicate it to patients and to meet the traceability requirements.
